<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Protein Folding and Misfolding - Enhanced</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: white;
            padding: 40px 20px;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: white;
        }
        
        .title {
            font-size: 32px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 30px;
            text-align: center;
        }
        
        .content-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 20px;
            margin-bottom: 50px;
        }
        
        .info-box {
            background: #f8f9fb;
            border-left: 4px solid #1E64C8;
            padding: 16px 18px;
            border-radius: 6px;
        }
        
        .info-title {
            font-size: 17px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 10px;
        }
        
        .info-content {
            font-size: 15px;
            color: #333;
            line-height: 1.5;
        }
        
        .bullet {
            display: flex;
            align-items: flex-start;
            margin-bottom: 6px;
        }
        
        .bullet::before {
            content: "•";
            color: #1E64C8;
            font-weight: bold;
            margin-right: 8px;
            font-size: 16px;
        }
        
        .detailed-section {
            margin-bottom: 60px;
            padding: 30px;
            background: #ffffff;
            border: 2px solid #e0e5eb;
            border-radius: 12px;
        }
        
        .section-header {
            font-size: 26px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 20px;
            padding-bottom: 15px;
            border-bottom: 3px solid #1E64C8;
        }
        
        .diagram-container {
            display: flex;
            justify-content: center;
            margin: 30px 0;
        }
        
        .description {
            font-size: 16px;
            line-height: 1.8;
            color: #333;
            margin-bottom: 20px;
        }
        
        .subsection {
            margin-top: 20px;
            padding: 15px;
            background: #f8f9fb;
            border-radius: 8px;
        }
        
        .subsection-title {
            font-size: 18px;
            font-weight: 600;
            color: #2c5aa0;
            margin-bottom: 10px;
        }
        
        .highlight-box {
            background: #e8f2ff;
            padding: 15px;
            border-radius: 8px;
            margin: 15px 0;
            border-left: 4px solid #1E64C8;
        }
        
        svg {
            max-width: 100%;
            height: auto;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="title">Protein Folding and Misfolding</div>
        
        <div class="content-grid">
            <div class="info-box">
                <div class="info-title">Anfinsen's Principle</div>
                <div class="info-content">
                    <div class="bullet">Sequence determines structure</div>
                    <div class="bullet">Spontaneous folding possible</div>
                    <div class="bullet">Minimum free energy state</div>
                    <div class="bullet">Reversible denaturation</div>
                </div>
            </div>
            
            <div class="info-box">
                <div class="info-title">Chaperone Proteins</div>
                <div class="info-content">
                    <div class="bullet">Assist protein folding</div>
                    <div class="bullet">Prevent aggregation</div>
                    <div class="bullet">HSP70, HSP90 families</div>
                    <div class="bullet">ATP-dependent mechanisms</div>
                </div>
            </div>
            
            <div class="info-box">
                <div class="info-title">Folding Funnels</div>
                <div class="info-content">
                    <div class="bullet">Energy landscape model</div>
                    <div class="bullet">Multiple pathways to native state</div>
                    <div class="bullet">Local minima can trap</div>
                    <div class="bullet">Kinetic vs thermodynamic control</div>
                </div>
            </div>
            
            <div class="info-box">
                <div class="info-title">Misfolding Diseases</div>
                <div class="info-content">
                    <div class="bullet">Alzheimer's: Aβ plaques</div>
                    <div class="bullet">Parkinson's: α-synuclein</div>
                    <div class="bullet">Prion diseases: PrP</div>
                    <div class="bullet">Therapeutic targets</div>
                </div>
            </div>
        </div>

        <!-- Detailed Section 1: Anfinsen's Principle -->
        <div class="detailed-section">
            <div class="section-header">1. Anfinsen's Principle: The Foundation of Protein Folding</div>
            
            <div class="description">
                Christian Anfinsen's groundbreaking work in the 1960s demonstrated that the three-dimensional structure of a protein is determined solely by its amino acid sequence. His experiments with ribonuclease A proved that proteins could spontaneously refold after denaturation, earning him the Nobel Prize in Chemistry in 1972.
            </div>

            <div class="diagram-container">
                <svg width="800" height="300" viewBox="0 0 800 300">
                    <!-- Native State -->
                    <g>
                        <ellipse cx="120" cy="150" rx="60" ry="80" fill="#4CAF50" opacity="0.7" stroke="#2E7D32" stroke-width="3"/>
                        <text x="120" y="250" text-anchor="middle" font-size="16" font-weight="600" fill="#333">Native State</text>
                        <text x="120" y="270" text-anchor="middle" font-size="14" fill="#666">Functional</text>
                    </g>

                    <!-- Arrow to Denatured -->
                    <g>
                        <line x1="190" y1="130" x2="270" y2="130" stroke="#FF5722" stroke-width="3" marker-end="url(#arrowred)"/>
                        <text x="230" y="120" text-anchor="middle" font-size="14" fill="#FF5722" font-weight="600">Denature</text>
                        <text x="230" y="105" text-anchor="middle" font-size="12" fill="#FF5722">(Urea/Heat)</text>
                    </g>

                    <!-- Denatured State -->
                    <g>
                        <path d="M 350 120 Q 370 100, 390 120 Q 410 140, 430 130 Q 450 120, 470 140 Q 490 160, 510 150" 
                              stroke="#FF5722" stroke-width="4" fill="none" stroke-dasharray="5,5"/>
                        <text x="430" y="250" text-anchor="middle" font-size="16" font-weight="600" fill="#333">Denatured State</text>
                        <text x="430" y="270" text-anchor="middle" font-size="14" fill="#666">Unfolded</text>
                    </g>

                    <!-- Arrow to Refolded -->
                    <g>
                        <line x1="550" y1="150" x2="630" y2="150" stroke="#4CAF50" stroke-width="3" marker-end="url(#arrowgreen)"/>
                        <text x="590" y="140" text-anchor="middle" font-size="14" fill="#4CAF50" font-weight="600">Refold</text>
                        <text x="590" y="125" text-anchor="middle" font-size="12" fill="#4CAF50">(Remove denaturant)</text>
                    </g>

                    <!-- Refolded State -->
                    <g>
                        <ellipse cx="700" cy="150" rx="60" ry="80" fill="#4CAF50" opacity="0.7" stroke="#2E7D32" stroke-width="3"/>
                        <text x="700" y="250" text-anchor="middle" font-size="16" font-weight="600" fill="#333">Refolded State</text>
                        <text x="700" y="270" text-anchor="middle" font-size="14" fill="#666">Identical to Native</text>
                    </g>

                    <!-- Arrow markers -->
                    <defs>
                        <marker id="arrowred" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto" markerUnits="strokeWidth">
                            <path d="M0,0 L0,6 L9,3 z" fill="#FF5722" />
                        </marker>
                        <marker id="arrowgreen" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto" markerUnits="strokeWidth">
                            <path d="M0,0 L0,6 L9,3 z" fill="#4CAF50" />
                        </marker>
                    </defs>
                </svg>
            </div>

            <div class="subsection">
                <div class="subsection-title">Key Experimental Evidence</div>
                <div class="description">
                    Anfinsen denatured ribonuclease A using urea and β-mercaptoethanol to break disulfide bonds. Upon removal of these denaturants, the enzyme spontaneously refolded to its native, catalytically active structure with correct disulfide bond formation. This demonstrated that all information needed for proper folding is encoded in the primary sequence.
                </div>
            </div>

            <div class="highlight-box">
                <strong>Thermodynamic Principle:</strong> The native structure represents the global minimum of free energy under physiological conditions. The protein spontaneously adopts this conformation because it is the most thermodynamically stable state, with optimal balance between enthalpic (hydrogen bonds, van der Waals forces) and entropic contributions.
            </div>

            <div class="subsection">
                <div class="subsection-title">Implications</div>
                <div class="description">
                    • <strong>Predictability:</strong> In principle, protein structure can be predicted from sequence alone<br>
                    • <strong>Evolution:</strong> Natural selection acts on sequences to optimize folding and function<br>
                    • <strong>Mutations:</strong> Changes in sequence can disrupt folding, leading to disease<br>
                    • <strong>Biotechnology:</strong> Recombinant proteins can fold correctly in heterologous systems
                </div>
            </div>
        </div>

        <!-- Detailed Section 2: Chaperone Proteins -->
        <div class="detailed-section">
            <div class="section-header">2. Chaperone Proteins: Cellular Folding Assistants</div>
            
            <div class="description">
                While Anfinsen's principle shows that spontaneous folding is possible in vitro, the crowded cellular environment presents significant challenges. Molecular chaperones are specialized proteins that facilitate proper folding, prevent aggregation, and help maintain protein homeostasis (proteostasis) in cells.
            </div>

            <div class="diagram-container">
                <svg width="900" height="400" viewBox="0 0 900 400">
                    <!-- Nascent protein -->
                    <g>
                        <path d="M 50 200 L 120 200" stroke="#FF9800" stroke-width="6" fill="none"/>
                        <circle cx="140" cy="200" r="8" fill="#FF9800"/>
                        <text x="85" y="240" text-anchor="middle" font-size="14" fill="#333">Nascent</text>
                        <text x="85" y="258" text-anchor="middle" font-size="14" fill="#333">polypeptide</text>
                    </g>

                    <!-- HSP70 binding -->
                    <g>
                        <rect x="200" y="160" width="120" height="80" rx="10" fill="#2196F3" opacity="0.3" stroke="#1976D2" stroke-width="2"/>
                        <path d="M 220 190 Q 240 175, 260 190 L 270 195" stroke="#FF9800" stroke-width="4" fill="none"/>
                        <text x="260" y="215" text-anchor="middle" font-size="14" font-weight="600" fill="#1976D2">HSP70</text>
                        <text x="260" y="270" text-anchor="middle" font-size="12" fill="#333">Binds hydrophobic</text>
                        <text x="260" y="286" text-anchor="middle" font-size="12" fill="#333">regions</text>
                        
                        <!-- ATP -->
                        <circle cx="300" cy="175" r="12" fill="#FFC107" stroke="#FF6F00" stroke-width="2"/>
                        <text x="300" y="180" text-anchor="middle" font-size="10" font-weight="600" fill="#333">ATP</text>
                    </g>

                    <text x="360" y="205" text-anchor="middle" font-size="20" fill="#666">→</text>

                    <!-- HSP90 or GroEL/ES -->
                    <g>
                        <!-- Barrel structure -->
                        <ellipse cx="480" cy="160" rx="70" ry="25" fill="none" stroke="#9C27B0" stroke-width="3"/>
                        <ellipse cx="480" cy="240" rx="70" ry="25" fill="none" stroke="#9C27B0" stroke-width="3"/>
                        <line x1="410" y1="160" x2="410" y2="240" stroke="#9C27B0" stroke-width="3"/>
                        <line x1="550" y1="160" x2="550" y2="240" stroke="#9C27B0" stroke-width="3"/>
                        
                        <!-- Protein inside -->
                        <path d="M 460 190 Q 470 180, 480 190 Q 490 200, 500 190 Q 510 180, 520 195" 
                              stroke="#FF9800" stroke-width="4" fill="none"/>
                        
                        <text x="480" y="280" text-anchor="middle" font-size="14" font-weight="600" fill="#9C27B0">GroEL/ES</text>
                        <text x="480" y="298" text-anchor="middle" font-size="12" fill="#333">Isolated folding</text>
                        <text x="480" y="314" text-anchor="middle" font-size="12" fill="#333">chamber</text>
                    </g>

                    <text x="590" y="205" text-anchor="middle" font-size="20" fill="#666">→</text>

                    <!-- Properly folded -->
                    <g>
                        <ellipse cx="680" cy="200" rx="50" ry="65" fill="#4CAF50" opacity="0.6" stroke="#2E7D32" stroke-width="3"/>
                        <text x="680" y="285" text-anchor="middle" font-size="14" font-weight="600" fill="#333">Native</text>
                        <text x="680" y="303" text-anchor="middle" font-size="14" font-weight="600" fill="#333">Structure</text>
                    </g>

                    <!-- Misfolded pathway -->
                    <g>
                        <line x1="480" y1="265" x2="480" y2="310" stroke="#E91E63" stroke-width="2" stroke-dasharray="5,5"/>
                        <text x="480" y="330" text-anchor="middle" font-size="12" fill="#E91E63">If misfolded</text>
                        
                        <!-- Aggregate -->
                        <g transform="translate(430, 340)">
                            <circle cx="0" cy="0" r="15" fill="#E91E63" opacity="0.5"/>
                            <circle cx="25" cy="8" r="15" fill="#E91E63" opacity="0.5"/>
                            <circle cx="50" cy="0" r="15" fill="#E91E63" opacity="0.5"/>
                            <circle cx="70" cy="10" r="15" fill="#E91E63" opacity="0.5"/>
                            <circle cx="95" cy="5" r="15" fill="#E91E63" opacity="0.5"/>
                        </g>
                        <text x="480" y="385" text-anchor="middle" font-size="12" fill="#E91E63" font-weight="600">Aggregates</text>
                    </g>

                    <!-- Arrows -->
                    <path d="M 150 200 L 190 200" stroke="#333" stroke-width="2" marker-end="url(#arrow1)"/>
                    <path d="M 330 200 L 390 200" stroke="#333" stroke-width="2" marker-end="url(#arrow1)"/>
                    <path d="M 560 200 L 620 200" stroke="#333" stroke-width="2" marker-end="url(#arrow1)"/>

                    <defs>
                        <marker id="arrow1" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <path d="M0,0 L0,6 L9,3 z" fill="#333" />
                        </marker>
                    </defs>
                </svg>
            </div>

            <div class="subsection">
                <div class="subsection-title">Major Chaperone Families</div>
                <div class="description">
                    <strong>1. HSP70 Family:</strong> Binds to hydrophobic patches on nascent or misfolded proteins, preventing aggregation. Uses ATP hydrolysis to regulate binding affinity. Works co-translationally (during synthesis) and post-translationally.<br><br>
                    
                    <strong>2. HSP90 Family:</strong> Involved in later stages of folding, particularly for signaling proteins and kinases. Essential for maturation of many regulatory proteins.<br><br>
                    
                    <strong>3. Chaperonins (GroEL/GroES in bacteria, CCT/TRiC in eukaryotes):</strong> Large barrel-shaped complexes that encapsulate unfolded proteins in an isolated chamber, allowing folding without aggregation. Can accommodate proteins up to ~60 kDa.<br><br>
                    
                    <strong>4. Small HSPs:</strong> Hold misfolded proteins in folding-competent states, preventing irreversible aggregation until other chaperones can assist refolding.
                </div>
            </div>

            <div class="highlight-box">
                <strong>ATP-Dependent Mechanism:</strong> Most chaperones use ATP hydrolysis to power conformational changes that regulate substrate binding and release. This energy input allows chaperones to actively rescue proteins from kinetically trapped misfolded states, going beyond what thermodynamics alone would permit.
            </div>

            <div class="subsection">
                <div class="subsection-title">Cellular Stress Response</div>
                <div class="description">
                    Heat shock proteins (HSPs) are dramatically upregulated during cellular stress conditions (heat, oxidative stress, heavy metals). This <strong>heat shock response</strong> helps maintain proteostasis by increasing the cellular capacity to prevent aggregation and refold damaged proteins. Transcription factor HSF1 (Heat Shock Factor 1) mediates this protective response.
                </div>
            </div>
        </div>

        <!-- Detailed Section 3: Folding Funnels -->
        <div class="detailed-section">
            <div class="section-header">3. Folding Funnels: The Energy Landscape Perspective</div>
            
            <div class="description">
                The folding funnel model, developed in the 1990s, revolutionized our understanding of protein folding by viewing it as a stochastic search through an energy landscape rather than a predetermined pathway. This framework explains how proteins can fold rapidly despite the astronomical number of possible conformations (Levinthal's paradox).
            </div>

            <div class="diagram-container">
                <svg width="700" height="500" viewBox="0 0 700 500">
                    <!-- Funnel shape -->
                    <defs>
                        <linearGradient id="funnelGradient" x1="0%" y1="0%" x2="0%" y2="100%">
                            <stop offset="0%" style="stop-color:#FF5722;stop-opacity:0.3" />
                            <stop offset="50%" style="stop-color:#FFC107;stop-opacity:0.3" />
                            <stop offset="100%" style="stop-color:#4CAF50;stop-opacity:0.5" />
                        </linearGradient>
                    </defs>
                    
                    <!-- Funnel outline -->
                    <path d="M 150 80 L 100 400 L 600 400 L 550 80 Z" fill="url(#funnelGradient)" stroke="#333" stroke-width="2"/>
                    
                    <!-- Energy axis -->
                    <line x1="50" y1="80" x2="50" y2="430" stroke="#333" stroke-width="2" marker-end="url(#arrowdown)"/>
                    <text x="30" y="250" text-anchor="middle" font-size="16" font-weight="600" fill="#333" transform="rotate(-90, 30, 250)">Free Energy (G)</text>
                    
                    <!-- Conformational diversity axis -->
                    <line x1="100" y1="450" x2="600" y2="450" stroke="#333" stroke-width="2" marker-end="url(#arrowright)"/>
                    <text x="350" y="480" text-anchor="middle" font-size="16" font-weight="600" fill="#333">Conformational Entropy</text>
                    
                    <!-- Unfolded states at top -->
                    <g>
                        <circle cx="200" cy="120" r="8" fill="#FF5722" opacity="0.7"/>
                        <circle cx="280" cy="110" r="8" fill="#FF5722" opacity="0.7"/>
                        <circle cx="350" cy="125" r="8" fill="#FF5722" opacity="0.7"/>
                        <circle cx="420" cy="115" r="8" fill="#FF5722" opacity="0.7"/>
                        <circle cx="500" cy="130" r="8" fill="#FF5722" opacity="0.7"/>
                        <text x="350" y="65" text-anchor="middle" font-size="14" font-weight="600" fill="#FF5722">Unfolded Ensemble</text>
                        <text x="350" y="50" text-anchor="middle" font-size="12" fill="#666">(High entropy, many conformations)</text>
                    </g>
                    
                    <!-- Folding pathways -->
                    <path d="M 200 120 Q 220 180, 240 240 Q 260 300, 280 360 L 320 390" 
                          stroke="#FF9800" stroke-width="3" fill="none" opacity="0.6" stroke-dasharray="5,5"/>
                    <path d="M 350 125 Q 340 200, 330 270 Q 325 330, 330 380" 
                          stroke="#FF9800" stroke-width="3" fill="none" opacity="0.6" stroke-dasharray="5,5"/>
                    <path d="M 500 130 Q 460 210, 420 280 Q 380 340, 360 385" 
                          stroke="#FF9800" stroke-width="3" fill="none" opacity="0.6" stroke-dasharray="5,5"/>
                    
                    <!-- Local minima (kinetic traps) -->
                    <g>
                        <circle cx="180" cy="250" r="12" fill="#FFC107" stroke="#FF6F00" stroke-width="2"/>
                        <text x="180" y="230" text-anchor="middle" font-size="11" fill="#333" font-weight="600">Local</text>
                        <text x="180" y="220" text-anchor="middle" font-size="11" fill="#333" font-weight="600">minimum</text>
                        
                        <circle cx="480" cy="280" r="12" fill="#FFC107" stroke="#FF6F00" stroke-width="2"/>
                    </g>
                    
                    <!-- Intermediate states -->
                    <g>
                        <ellipse cx="300" cy="250" rx="40" ry="25" fill="#2196F3" opacity="0.3" stroke="#1976D2" stroke-width="2"/>
                        <text x="300" y="255" text-anchor="middle" font-size="12" font-weight="600" fill="#1976D2">Molten globule</text>
                        <text x="390" y="255" text-anchor="start" font-size="11" fill="#666">(Partially folded)</text>
                    </g>
                    
                    <!-- Native state at bottom -->
                    <g>
                        <ellipse cx="350" cy="395" rx="45" ry="20" fill="#4CAF50" opacity="0.8" stroke="#2E7D32" stroke-width="3"/>
                        <text x="350" y="400" text-anchor="middle" font-size="14" font-weight="600" fill="white">Native State</text>
                        <text x="450" y="395" text-anchor="start" font-size="12" fill="#333" font-weight="600">(Global minimum)</text>
                        <text x="450" y="410" text-anchor="start" font-size="11" fill="#666">(Low entropy, unique structure)</text>
                    </g>
                    
                    <!-- Annotations -->
                    <text x="620" y="150" text-anchor="start" font-size="13" fill="#FF5722" font-weight="600">High energy</text>
                    <text x="620" y="250" text-anchor="start" font-size="13" fill="#FFC107" font-weight="600">Intermediate</text>
                    <text x="620" y="380" text-anchor="start" font-size="13" fill="#4CAF50" font-weight="600">Low energy</text>
                    
                    <defs>
                        <marker id="arrowdown" markerWidth="10" markerHeight="10" refX="5" refY="9" orient="auto">
                            <path d="M0,0 L10,0 L5,9 z" fill="#333" />
                        </marker>
                        <marker id="arrowright" markerWidth="10" markerHeight="10" refX="9" refY="5" orient="auto">
                            <path d="M0,0 L0,10 L9,5 z" fill="#333" />
                        </marker>
                    </defs>
                </svg>
            </div>

            <div class="subsection">
                <div class="subsection-title">The Levinthal Paradox</div>
                <div class="description">
                    If a protein randomly sampled all possible conformations to find the lowest energy state, it would take longer than the age of the universe. However, proteins fold in milliseconds to seconds. The solution: <strong>proteins don't search randomly</strong>. The folding funnel shows that local interactions progressively guide the protein toward the native state through multiple parallel pathways, dramatically reducing the search space.
                </div>
            </div>

            <div class="highlight-box">
                <strong>Key Concept - Funnel Shape:</strong> The funnel narrows as conformational entropy decreases (fewer possible conformations) and free energy decreases (more stable structures). The rough surface represents local energy minima where proteins can temporarily get trapped. The overall downhill slope toward the native state explains why folding can be rapid despite complexity.
            </div>

            <div class="subsection">
                <div class="subsection-title">Folding Intermediates</div>
                <div class="description">
                    <strong>Molten Globule:</strong> A compact intermediate state with native-like secondary structure but fluctuating tertiary structure. Contains a hydrophobic core but lacks the tight packing of the native state.<br><br>
                    
                    <strong>Local Minima:</strong> Kinetic traps where proteins can get stuck in non-native conformations. Chaperones help proteins escape these traps by providing energy input or preventing premature collapse.<br><br>
                    
                    <strong>Transition State:</strong> The highest energy barrier along the folding pathway, analogous to the transition state in chemical reactions. Protein engineering studies of the transition state reveal which contacts form early versus late in folding.
                </div>
            </div>

            <div class="subsection">
                <div class="subsection-title">Kinetic vs. Thermodynamic Control</div>
                <div class="description">
                    <strong>Thermodynamic control:</strong> Under ideal conditions, proteins reach the global energy minimum (native state).<br><br>
                    
                    <strong>Kinetic control:</strong> In crowded cellular environments or during stress, proteins may get trapped in local minima, leading to kinetically stable but non-native states. This is where chaperones become essential, using ATP energy to overcome kinetic barriers and allow proteins to reach the thermodynamic minimum.
                </div>
            </div>
        </div>

        <!-- Detailed Section 4: Misfolding Diseases -->
        <div class="detailed-section">
            <div class="section-header">4. Misfolding Diseases: When Proteins Go Wrong</div>
            
            <div class="description">
                Protein misfolding diseases, or proteinopathies, occur when proteins fail to achieve or maintain their native structure, leading to loss of function, toxic gain of function, or formation of pathological aggregates. These diseases particularly affect long-lived cells like neurons, where protein quality control becomes compromised with age.
            </div>

            <div class="diagram-container">
                <svg width="850" height="450" viewBox="0 0 850 450">
                    <!-- Normal protein pathway -->
                    <g>
                        <ellipse cx="100" cy="80" rx="40" ry="30" fill="#4CAF50" opacity="0.7" stroke="#2E7D32" stroke-width="2"/>
                        <text x="100" y="85" text-anchor="middle" font-size="12" font-weight="600" fill="#fff">Normal</text>
                        <text x="100" y="130" text-anchor="middle" font-size="13" fill="#333" font-weight="600">Healthy State</text>
                        <path d="M 100 110 L 100 200" stroke="#4CAF50" stroke-width="2" marker-end="url(#greenarrow)"/>
                        <text x="100" y="230" text-anchor="middle" font-size="12" fill="#4CAF50">Proper function</text>
                    </g>

                    <!-- Misfolding trigger -->
                    <g>
                        <rect x="250" y="50" width="120" height="60" rx="5" fill="#FF9800" opacity="0.2" stroke="#F57C00" stroke-width="2"/>
                        <text x="310" y="75" text-anchor="middle" font-size="13" font-weight="600" fill="#333">Misfolding</text>
                        <text x="310" y="92" text-anchor="middle" font-size="13" font-weight="600" fill="#333">Triggers:</text>
                        <text x="310" y="135" text-anchor="middle" font-size="11" fill="#666">• Mutations</text>
                        <text x="310" y="150" text-anchor="middle" font-size="11" fill="#666">• Aging</text>
                        <text x="310" y="165" text-anchor="middle" font-size="11" fill="#666">• Oxidative stress</text>
                    </g>

                    <path d="M 150 80 L 240 80" stroke="#FF5722" stroke-width="2" marker-end="url(#redarrow)"/>

                    <!-- Disease pathways -->
                    <!-- Alzheimer's -->
                    <g>
                        <rect x="420" y="20" width="180" height="90" rx="8" fill="#E3F2FD" stroke="#2196F3" stroke-width="2"/>
                        <text x="510" y="45" text-anchor="middle" font-size="15" font-weight="600" fill="#1976D2">Alzheimer's Disease</text>
                        
                        <!-- Amyloid plaques -->
                        <g transform="translate(450, 60)">
                            <circle cx="0" cy="0" r="6" fill="#2196F3" opacity="0.6"/>
                            <circle cx="12" cy="4" r="6" fill="#2196F3" opacity="0.6"/>
                            <circle cx="24" cy="0" r="6" fill="#2196F3" opacity="0.6"/>
                            <circle cx="36" cy="4" r="6" fill="#2196F3" opacity="0.6"/>
                            <circle cx="48" cy="0" r="6" fill="#2196F3" opacity="0.6"/>
                            <circle cx="6" cy="12" r="6" fill="#2196F3" opacity="0.6"/>
                            <circle cx="18" cy="14" r="6" fill="#2196F3" opacity="0.6"/>
                            <circle cx="30" cy="12" r="6" fill="#2196F3" opacity="0.6"/>
                            <circle cx="42" cy="14" r="6" fill="#2196F3" opacity="0.6"/>
                        </g>
                        
                        <text x="510" y="90" text-anchor="middle" font-size="11" fill="#333">Aβ peptide → β-sheet</text>
                        <text x="510" y="103" text-anchor="middle" font-size="11" fill="#333">Extracellular plaques</text>
                    </g>

                    <path d="M 370 60 L 410 60" stroke="#E91E63" stroke-width="2" marker-end="url(#redarrow)"/>

                    <!-- Parkinson's -->
                    <g>
                        <rect x="420" y="140" width="180" height="90" rx="8" fill="#F3E5F5" stroke="#9C27B0" stroke-width="2"/>
                        <text x="510" y="165" text-anchor="middle" font-size="15" font-weight="600" fill="#7B1FA2">Parkinson's Disease</text>
                        
                        <!-- Lewy bodies -->
                        <ellipse cx="480" cy="195" rx="25" ry="20" fill="#9C27B0" opacity="0.3" stroke="#7B1FA2" stroke-width="2"/>
                        <path d="M 465 195 Q 475 185, 485 195 Q 495 205, 505 195" 
                              stroke="#7B1FA2" stroke-width="2" fill="none"/>
                        
                        <text x="540" y="195" text-anchor="middle" font-size="11" fill="#333">Lewy bodies</text>
                        <text x="510" y="223" text-anchor="middle" font-size="11" fill="#333">α-synuclein aggregates</text>
                    </g>

                    <path d="M 370 120 L 390 140 L 410 160" stroke="#E91E63" stroke-width="2" marker-end="url(#redarrow)"/>

                    <!-- Prion diseases -->
                    <g>
                        <rect x="420" y="260" width="180" height="90" rx="8" fill="#FFF3E0" stroke="#FF6F00" stroke-width="2"/>
                        <text x="510" y="285" text-anchor="middle" font-size="15" font-weight="600" fill="#E65100">Prion Diseases</text>
                        
                        <!-- Prion conversion -->
                        <g transform="translate(445, 300)">
                            <ellipse cx="15" cy="15" rx="12" ry="10" fill="#4CAF50" opacity="0.5" stroke="#2E7D32" stroke-width="1.5"/>
                            <text x="15" y="19" text-anchor="middle" font-size="9" fill="#333">PrPc</text>
                        </g>
                        
                        <text x="490" y="322" text-anchor="middle" font-size="16" fill="#FF6F00">→</text>
                        
                        <g transform="translate(510, 305)">
                            <rect x="0" y="0" width="45" height="20" fill="#FF6F00" opacity="0.5" stroke="#E65100" stroke-width="1.5"/>
                            <text x="22" y="14" text-anchor="middle" font-size="9" fill="#333">PrPsc</text>
                        </g>
                        
                        <text x="510" y="343" text-anchor="middle" font-size="11" fill="#333">Self-propagating</text>
                    </g>

                    <path d="M 370 180 L 390 220 L 410 260" stroke="#E91E63" stroke-width="2" marker-end="url(#redarrow)"/>

                    <!-- Common mechanisms -->
                    <g>
                        <rect x="650" y="140" width="180" height="140" rx="8" fill="#FFEBEE" stroke="#D32F2F" stroke-width="2"/>
                        <text x="740" y="165" text-anchor="middle" font-size="14" font-weight="600" fill="#C62828">Common Mechanisms</text>
                        
                        <text x="660" y="190" font-size="11" fill="#333">• Loss of normal function</text>
                        <text x="660" y="207" font-size="11" fill="#333">• Toxic oligomers</text>
                        <text x="660" y="224" font-size="11" fill="#333">• Membrane disruption</text>
                        <text x="660" y="241" font-size="11" fill="#333">• Mitochondrial damage</text>
                        <text x="660" y="258" font-size="11" fill="#333">• Impaired proteostasis</text>
                        <text x="660" y="275" font-size="11" fill="#333">• Neuroinflammation</text>
                    </g>

                    <path d="M 610 160 L 640 160" stroke="#E91E63" stroke-width="2" marker-end="url(#redarrow)"/>
                    <path d="M 610 200 L 640 200" stroke="#E91E63" stroke-width="2" marker-end="url(#redarrow)"/>
                    <path d="M 610 300 L 625 280 L 640 260" stroke="#E91E63" stroke-width="2" marker-end="url(#redarrow)"/>

                    <!-- Therapeutic approaches -->
                    <g>
                        <rect x="300" y="340" width="520" height="80" rx="8" fill="#E8F5E9" stroke="#388E3C" stroke-width="2"/>
                        <text x="560" y="365" text-anchor="middle" font-size="15" font-weight="600" fill="#2E7D32">Therapeutic Strategies</text>
                        
                        <text x="320" y="390" font-size="11" fill="#333">• Enhance chaperone function</text>
                        <text x="320" y="405" font-size="11" fill="#333">• Prevent aggregation</text>
                        
                        <text x="520" y="390" font-size="11" fill="#333">• Promote clearance (autophagy)</text>
                        <text x="520" y="405" font-size="11" fill="#333">• Stabilize native conformation</text>
                        
                        <text x="710" y="390" font-size="11" fill="#333">• Immunotherapy (antibodies)</text>
                        <text x="710" y="405" font-size="11" fill="#333">• Small molecule inhibitors</text>
                    </g>

                    <defs>
                        <marker id="greenarrow" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <path d="M0,0 L0,6 L9,3 z" fill="#4CAF50" />
                        </marker>
                        <marker id="redarrow" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <path d="M0,0 L0,6 L9,3 z" fill="#E91E63" />
                        </marker>
                    </defs>
                </svg>
            </div>

            <div class="subsection">
                <div class="subsection-title">Alzheimer's Disease</div>
                <div class="description">
                    <strong>Key Protein:</strong> Amyloid-β (Aβ) peptide, derived from cleavage of amyloid precursor protein (APP)<br><br>
                    
                    <strong>Mechanism:</strong> Aβ monomers undergo conformational change from α-helix/random coil to β-sheet structure, forming toxic oligomers and eventually insoluble extracellular plaques. Tau protein also misfolds, forming intracellular neurofibrillary tangles.<br><br>
                    
                    <strong>Pathology:</strong> Synaptic dysfunction, neuronal loss, cognitive decline, and dementia. Affects over 55 million people worldwide.<br><br>
                    
                    <strong>Current Treatments:</strong> Anti-amyloid antibodies (aducanumab, lecanemab) show modest benefits by clearing plaques, but significant side effects remain. Prevention strategies focus on modifiable risk factors.
                </div>
            </div>

            <div class="subsection">
                <div class="subsection-title">Parkinson's Disease</div>
                <div class="description">
                    <strong>Key Protein:</strong> α-synuclein<br><br>
                    
                    <strong>Mechanism:</strong> α-synuclein misfolds and aggregates into Lewy bodies within dopaminergic neurons of the substantia nigra. The protein normally exists as an unstructured monomer but adopts β-sheet-rich structures in disease.<br><br>
                    
                    <strong>Pathology:</strong> Progressive loss of dopaminergic neurons leads to motor symptoms (tremor, rigidity, bradykinesia) and non-motor symptoms (cognitive decline, depression). Second most common neurodegenerative disease.<br><br>
                    
                    <strong>Spreading:</strong> Evidence suggests α-synuclein pathology can spread from cell to cell in a prion-like manner, explaining disease progression patterns.
                </div>
            </div>

            <div class="subsection">
                <div class="subsection-title">Prion Diseases</div>
                <div class="description">
                    <strong>Key Protein:</strong> Prion protein (PrP)<br><br>
                    
                    <strong>Mechanism:</strong> The normal cellular form (PrPc) can be converted into a misfolded, β-sheet-rich scrapie form (PrPsc). PrPsc acts as a template, catalyzing the conversion of more PrPc into PrPsc in an autocatalytic, self-propagating manner.<br><br>
                    
                    <strong>Unique Features:</strong> Transmissible between individuals and even across species barriers (though with less efficiency). No nucleic acid required for transmission - protein alone carries infectivity.<br><br>
                    
                    <strong>Diseases:</strong> Creutzfeldt-Jakob disease (CJD), variant CJD (mad cow disease), kuru, fatal familial insomnia, Gerstmann-Sträussler-Scheinker syndrome. All are invariably fatal with no effective treatments.
                </div>
            </div>

            <div class="highlight-box">
                <strong>Toxic Oligomer Hypothesis:</strong> Recent research suggests that small, soluble oligomers of misfolded proteins (rather than large insoluble aggregates) may be the primary toxic species. These oligomers can disrupt membranes, impair synaptic function, and seed further aggregation. This has shifted therapeutic focus toward preventing oligomer formation and enhancing clearance.
            </div>

            <div class="subsection">
                <div class="subsection-title">Common Themes in Protein Misfolding Diseases</div>
                <div class="description">
                    • <strong>Age-related:</strong> Most manifest in older adults as protein quality control systems decline<br>
                    • <strong>Gain of toxic function:</strong> Aggregates interfere with cellular processes<br>
                    • <strong>Loss of native function:</strong> Sequestration of functional protein into aggregates<br>
                    • <strong>Seeding and spreading:</strong> Misfolded proteins can template misfolding of normal proteins<br>
                    • <strong>Selective vulnerability:</strong> Specific cell types affected despite widespread protein expression<br>
                    • <strong>Protein degradation failure:</strong> Overwhelmed ubiquitin-proteasome and autophagy systems<br>
                    • <strong>No curative treatments:</strong> Current therapies only manage symptoms or modestly slow progression
                </div>
            </div>

            <div class="subsection">
                <div class="subsection-title">Future Therapeutic Directions</div>
                <div class="description">
                    <strong>1. Chaperone Enhancement:</strong> Pharmacological upregulation of heat shock proteins to improve protein quality control<br><br>
                    
                    <strong>2. Aggregation Inhibitors:</strong> Small molecules that stabilize native conformations or prevent oligomerization<br><br>
                    
                    <strong>3. Immunotherapy:</strong> Antibodies targeting toxic species for clearance by immune system<br><br>
                    
                    <strong>4. Autophagy Enhancement:</strong> Promoting cellular clearance mechanisms to remove aggregates<br><br>
                    
                    <strong>5. Gene Therapy:</strong> Reducing expression of disease proteins or enhancing protective factors<br><br>
                    
                    <strong>6. Early Intervention:</strong> Biomarker development for pre-symptomatic diagnosis and treatment
                </div>
            </div>
        </div>

    </div>
</body>
</html>